Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRent ExpenseShares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

National Healthcare (NHC) Loans and Notes Receivables (2016 - 2025)

National Healthcare's Loans and Notes Receivables history spans 15 years, with the latest figure at $505000.0 for Q1 2025.

  • For Q1 2025, Loans and Notes Receivables rose 3.7% year-over-year to $505000.0; the TTM value through Mar 2025 reached $505000.0, up 3.7%, while the annual FY2024 figure was $512000.0, 1.79% up from the prior year.
  • Loans and Notes Receivables reached $505000.0 in Q1 2025 per NHC's latest filing, down from $512000.0 in the prior quarter.
  • In the past five years, Loans and Notes Receivables ranged from a high of $8.8 million in Q1 2021 to a low of $302000.0 in Q4 2022.
  • Average Loans and Notes Receivables over 5 years is $1.3 million, with a median of $512000.0 recorded in 2024.
  • The largest YoY upside for Loans and Notes Receivables was 393.22% in 2021 against a maximum downside of 51.19% in 2021.
  • A 5-year view of Loans and Notes Receivables shows it stood at $453000.0 in 2021, then tumbled by 33.33% to $302000.0 in 2022, then surged by 66.56% to $503000.0 in 2023, then increased by 1.79% to $512000.0 in 2024, then decreased by 1.37% to $505000.0 in 2025.
  • Per Business Quant, the three most recent readings for NHC's Loans and Notes Receivables are $505000.0 (Q1 2025), $512000.0 (Q4 2024), and $578000.0 (Q3 2024).